Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011

Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period

(2012) Gaston De Serres et al.   VACCINE

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme

(2012) Helene Ingels et al.   VACCINE

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

(2012) Nick J. Andrews et al.   VACCINE

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases

(2012) Angel Vila-Corcoles et al.   Human Vaccines & Immunotherapeutics

Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage

(2011) D. Rolo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002–2009: An increase in serotypes not contained in the heptavalent conjugate vaccine

(2011) Olga Ochoa-Gondar et al.   JOURNAL OF INFECTION

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

(2011) Carmen Muñoz-Almagro et al.   JOURNAL OF INFECTION

Serotype replacement in disease after pneumococcal vaccination

(2011) Daniel M Weinberger et al.   LANCET

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children

(2011) Anna S. Tocheva et al.   VACCINE

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

(2011) Elizabeth Miller et al.   VACCINE

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

(2010) Germaine Hanquet et al.   VACCINE

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

(2009) M. Guevara et al.   CLINICAL MICROBIOLOGY AND INFECTION

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

(2008) John D Mooney et al.   BMC INFECTIOUS DISEASES

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

(2008) Carmen Ardanuy et al.   CLINICAL INFECTIOUS DISEASES

Alternative strategies for adult pneumococcal polysaccharide vaccination: A cost-effectiveness analysis

(2008) Kenneth J. Smith et al.   VACCINE